Communiqué de presse : Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée
Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée Aux États-Unis, le Dupixent est indiqué à…
Correction: Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l’exercice 2025
ERRATUM – ANNULE ET REMPLACE Nous regrettons une erreur dans le tableau inclus dans le communiqué de presse en français. Merci de le remplacer par celui-ci. Croissance des ventes de…
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary…
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
The agreement would facilitate providing Tevogen Bio with in-house cell therapy production capabilitiesFormalized agreement aligns with previously announced topline forecasts WARREN, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio…
CORRECTION NOTICE: Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call
RESTON, VA, April 16, 2025 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its third quarter fiscal year 2025 financial results during a conference call…
SPINEWAY : Chiffre d’affaires du 1er trimestre 2025 de 2,8 M€
Communiqué de presse Ecully, le 16 avril 2025 – 19h SPINEWAY Chiffre d’affaires du 1er trimestre 2025 de 2,8 M€ En milliers d’euros20252024Variation en %CA 1er trimestre2 8283 070- 8%…
Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 15 04 2025]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Spineway : First-quarter 2025 revenue of €2.8 million
Press release Ecully, April 16, 2025 – 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated data Spineway, a specialist…
Montero Announces Share Consolidation and C$15M Return of Capital
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Montero Mining and Exploration Ltd. (TSX-V: MON) (OTCPK: MXTRF) (“Montero” or the “Company”) announces that it has finalized its planned uses of the…
Mx2 Mining Completes Transaction with Aya Gold & Silver
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Mx2 Mining Inc. (“Mx2” or the “Company”) is pleased to announce the completion of the previously announced transaction with Aya Gold & Silver…